In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models

PURPOSE: Dry eye disease (DED) is a multifactorial disorder of the tears and ocular surface accompanied by ocular discomfort, visual disturbance, tear film instability, and ocular surface inflammation. In the present study, we evaluated the efficacy of the tyrosine kinase inhibitor imatinib mesylate...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Yi-Yong, Sung, Bokyung, Choi, Jun-Sub, Go, Hyeon-Kyu, Kim, Do-Hyung, Hyon, Joon Young, You, Ji Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444463/
https://www.ncbi.nlm.nih.gov/pubmed/34520512
http://dx.doi.org/10.1167/tvst.10.11.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444463/
https://www.ncbi.nlm.nih.gov/pubmed/34520512
http://dx.doi.org/10.1167/tvst.10.11.14

Ejemplares similares